| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Budget Impact Model of Maintenance Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with IgPro20 (Hizentra) Relative to Intravenous Immunoglobulin in the United States
|
Mallick, Rajiv
|
|
|
|
2 |
p. 243-255
|
artikel
|
| 2 |
A Comparison of Inpatient Cost Per Day in General Surgery Patients with Type 2 Diabetes Treated with Basal-Bolus versus Sliding Scale Insulin Regimens
|
Phillips, Victoria L.
|
|
2017
|
|
2 |
p. 109-115
|
artikel
|
| 3 |
Adherence, Healthcare Resource Utilization, and Costs in Medicaid Beneficiaries with Schizophrenia Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate
|
Emond, Bruno
|
|
2018
|
|
2 |
p. 177-188
|
artikel
|
| 4 |
A Framework for a Health Economic Evaluation Model for Patients with Sickle Cell Disease to Estimate the Value of New Treatments in the United States of America
|
Winn, Aaron
|
|
|
|
2 |
p. 313-320
|
artikel
|
| 5 |
An Analysis of Uncertainties and Data Collection Agreements in the Cancer Drugs Fund
|
Trigg, Laura A.
|
|
|
|
2 |
p. 303-311
|
artikel
|
| 6 |
A Nationwide Study of Prevalence Rates and Characteristics of 199 Chronic Conditions in Denmark
|
Hvidberg, Michael Falk
|
|
|
|
2 |
p. 361-380
|
artikel
|
| 7 |
An Exploration on Attribute Non-attendance Using Discrete Choice Experiment Data from the Irish EQ-5D-5L National Valuation Study
|
Doherty, Edel
|
|
|
|
2 |
p. 237-244
|
artikel
|
| 8 |
Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)
|
Garau, Martina
|
|
2017
|
|
2 |
p. 153-163
|
artikel
|
| 9 |
A Probabilistic Cost-Effectiveness Analysis of Venetoclax and Obinutuzumab as a First-Line Therapy in Chronic Lymphocytic Leukemia in Canada
|
Chatterjee, Anuja
|
|
|
|
2 |
p. 199-216
|
artikel
|
| 10 |
Artificial Intelligence to Automate Health Economic Modelling: A Case Study to Evaluate the Potential Application of Large Language Models
|
Reason, Tim
|
|
|
|
2 |
p. 191-203
|
artikel
|
| 11 |
Artificial Intelligence to Automate Network Meta-Analyses: Four Case Studies to Evaluate the Potential Application of Large Language Models
|
Reason, Tim
|
|
|
|
2 |
p. 205-220
|
artikel
|
| 12 |
A Systematic Literature Review of Health-Related Quality of Life Outcomes and Associated Utility Values in Relapsed and/or Refractory Large B Cell Lymphoma
|
Liu, Fei Fei
|
|
|
|
2 |
p. 171-190
|
artikel
|
| 13 |
A Systematic Review of Model-Based Economic Evaluations of Treatments for Venous Leg Ulcers
|
Layer, Ashley
|
|
|
|
2 |
p. 211-222
|
artikel
|
| 14 |
Attributable Cost of Adult Hospitalized Pneumonia Beyond the Acute Phase
|
Weycker, Derek
|
|
|
|
2 |
p. 275-284
|
artikel
|
| 15 |
Attributable Patient Cost of Antimicrobial Resistance: A Prospective Parallel Cohort Study in Two Public Teaching Hospitals in Ghana
|
Otieku, Evans
|
|
|
|
2 |
p. 257-271
|
artikel
|
| 16 |
Budget Impact Analysis of an Epigenetic Test Used for Diagnosing Fetal Alcohol Spectrum Disorder from the Perspective of a Laboratory Budget Holder in Manitoba, Canada
|
Berrigan, Patrick
|
|
|
|
2 |
p. 253-263
|
artikel
|
| 17 |
Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands
|
Gout-Zwart, Judith J.
|
|
|
|
2 |
p. 321-330
|
artikel
|
| 18 |
Budget Impact of the Vest™ High Frequency Chest Wall Oscillation System for Managing Airway Clearance in Patients with Complex Neurological Disorders: A US Healthcare Payers’ Perspective Analysis
|
Ansaripour, Amir
|
|
|
|
2 |
p. 169-178
|
artikel
|
| 19 |
Can Private Provision of Primary Care Contribute to the Spread of Antibiotic Resistance? A Study of Antibiotic Prescription in Sweden
|
Granlund, David
|
|
|
|
2 |
p. 187-195
|
artikel
|
| 20 |
Correction: From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy
|
Rossini, Elvio Emanuele
|
|
|
|
2 |
p. 345
|
artikel
|
| 21 |
Correction to: Cost-Effectiveness Analysis of Single-Use EEG Cup Electrodes Compared with Reusable EEG Cup Electrodes
|
Sohrt, Anne
|
|
2019
|
|
2 |
p. 275
|
artikel
|
| 22 |
Correction to: Cost-Effectiveness Analysis of Single-Use EEG Cup Electrodes Compared with Reusable EEG Cup Electrodes
|
Sohrt, Anne
|
|
2018
|
|
2 |
p. 273
|
artikel
|
| 23 |
Correction to: Which Costs Matter? Costs Included in Economic Evaluation and their Impact on Decision Uncertainty for Stable Coronary Artery Disease
|
Lomas, James
|
|
2019
|
|
2 |
p. 277
|
artikel
|
| 24 |
Cost-Benefit Analysis of Telemedicine Systems/Units in Greek Remote Areas
|
Kouskoukis, Marios-Nikolaos
|
|
2016
|
|
2 |
p. 117-121
|
artikel
|
| 25 |
Cost Comparison of Single-Use Versus Reusable Bronchoscopes Used for Percutaneous Dilatational Tracheostomy
|
Sohrt, Anne
|
|
2018
|
|
2 |
p. 189-195
|
artikel
|
| 26 |
Cost-Effectiveness Analysis of Abrocitinib Compared with Other Systemic Treatments for Severe Atopic Dermatitis in Spain
|
Romero Jiménez, Rosa María
|
|
|
|
2 |
p. 291-302
|
artikel
|
| 27 |
Cost-Effectiveness Analysis of Adjuvant Olaparib Versus Watch and Wait in the Treatment of Germline BRCA1/2-Mutated, High-Risk, HER2-Negative Early Breast Cancer in Sweden
|
Polyzoi, Maria
|
|
|
|
2 |
p. 277-289
|
artikel
|
| 28 |
Cost-Effectiveness Analysis of Evolocumab for the Treatment of Dyslipidemia in the Kingdom of Saudi Arabia
|
Alghamdi, Ahmed
|
|
|
|
2 |
p. 277-291
|
artikel
|
| 29 |
Cost-Effectiveness Analysis of Exenatide versus GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus
|
Capel, Margarita
|
|
|
|
2 |
p. 277-286
|
artikel
|
| 30 |
Cost-effectiveness Analysis of Ocrelizumab for the Treatment of Relapsing and Primary Progressive Multiple Sclerosis in Portugal
|
Martins, Paulo
|
|
|
|
2 |
p. 229-241
|
artikel
|
| 31 |
Cost-Effectiveness Analysis of Single-Use EEG Cup Electrodes Compared with Reusable EEG Cup Electrodes
|
Sohrt, Anne
|
|
2018
|
|
2 |
p. 265-272
|
artikel
|
| 32 |
Cost Effectiveness of Durvalumab in Unresectable Stage III NSCLC: 4-Year Survival Update and Model Validation from a UK Healthcare Perspective
|
Dunlop, Will
|
|
|
|
2 |
p. 241-252
|
artikel
|
| 33 |
Cost Effectiveness of Internet-Delivered Acceptance and Commitment Therapy for Patients with Severe Health Anxiety: A Randomised Controlled Trial
|
Risør, Bettina Wulff
|
|
|
|
2 |
p. 179-192
|
artikel
|
| 34 |
Cost Effectiveness of Nivolumab in Patients with Advanced, Previously Treated Squamous and Non-squamous Non-small-cell Lung Cancer in England
|
Rothwell, Ben
|
|
|
|
2 |
p. 251-260
|
artikel
|
| 35 |
Cost Effectiveness of PD-L1-Based Test-and-Treat Strategy with Pembrolizumab as the First-Line Treatment for Metastatic NSCLC in Hong Kong
|
Loong, Herbert H.
|
|
|
|
2 |
p. 235-247
|
artikel
|
| 36 |
Cost of Delivering Secondary Healthcare Through the Public Sector in India
|
Prinja, Shankar
|
|
|
|
2 |
p. 249-261
|
artikel
|
| 37 |
Cost of Illness in Patients with Duchenne Muscular Dystrophy in Portugal: The COIDUCH Study
|
Labisa, Pedro
|
|
|
|
2 |
p. 211-218
|
artikel
|
| 38 |
Cost of Intensive Care Treatment for Liver Disorders at Tertiary Care Level in India
|
Prinja, Shankar
|
|
2017
|
|
2 |
p. 179-190
|
artikel
|
| 39 |
Cost of Revision Total Knee Replacement: A Protocol for Systematic Review and Meta-Analysis
|
Okafor, Charles Ebuka
|
|
|
|
2 |
p. 331-337
|
artikel
|
| 40 |
Cost-Utility Analysis of the Caresyntax Platform to Identify Patients at Risk of Surgical Site Infection Undergoing Colorectal Surgery
|
Moloney, Eoin
|
|
|
|
2 |
p. 285-298
|
artikel
|
| 41 |
Cost-Utility Analysis of Total Ankle Replacement Compared with Ankle Arthrodesis for Patients Aged 50–85 Years with End-Stage Ankle Osteoarthritis: The TARVA Study
|
Goldberg, Andrew J.
|
|
|
|
2 |
p. 235-249
|
artikel
|
| 42 |
Delineating the Type 2 Diabetes Population in the Netherlands Using an All-Payer Claims Database: Specialist Care, Medication Utilization and Expenditures 2016–2018
|
Geurten, Rose J.
|
|
|
|
2 |
p. 219-229
|
artikel
|
| 43 |
Direct Mapping of the QLQ-C30 to EQ-5D Preferences: A Comparison of Regression Methods
|
Crott, Ralph
|
|
2017
|
|
2 |
p. 165-177
|
artikel
|
| 44 |
Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis
|
Charbonnel, Bernard
|
|
2017
|
|
2 |
p. 209-219
|
artikel
|
| 45 |
Disparities in the Wage-and-Salary Earnings, Determinants, and Distribution of Health Economics, Outcomes Research, and Market Access Professionals: An Exploratory Study
|
Popovici, Ioana
|
|
|
|
2 |
p. 319-329
|
artikel
|
| 46 |
Does Methodological Guidance Produce Consistency? A Review of Methodological Consistency in Breast Cancer Utility Value Measurement in NICE Single Technology Appraisals
|
Rose, Micah
|
|
2017
|
|
2 |
p. 97-107
|
artikel
|
| 47 |
Does Structured Exercise Improve Cognitive Impairment in People with Mild to Moderate Dementia? A Cost-Effectiveness Analysis from a Confirmatory Randomised Controlled Trial: The Dementia and Physical Activity (DAPA) Trial
|
Khan, Iftekhar
|
|
2018
|
|
2 |
p. 215-227
|
artikel
|
| 48 |
Early Assessment of the Likely Cost Effectiveness of Single-Use Flexible Video Bronchoscopes
|
Terjesen, Christoffer Lilja
|
|
2017
|
|
2 |
p. 133-141
|
artikel
|
| 49 |
Economic Burden of Patients Treated for Higher-Risk Myelodysplastic Syndromes (HR-MDS) in Routine Clinical Care in the United States
|
Bell, Jill A.
|
|
2018
|
|
2 |
p. 237-245
|
artikel
|
| 50 |
Economic Evaluation of a Personalized Nutrition Plan Based on Omic Sciences Versus a General Nutrition Plan in Adults with Overweight and Obesity: A Modeling Study Based on Trial Data in Denmark
|
Galekop, Milanne Maria Johanna
|
|
|
|
2 |
p. 313-331
|
artikel
|
| 51 |
Economic Evaluation of Azacitidine in Elderly Patients with Acute Myeloid Leukemia with High Blast Counts
|
Coyle, D.
|
|
|
|
2 |
p. 297-305
|
artikel
|
| 52 |
Economic Evaluation of Midazolam–Droperidol Combination, Versus Droperidol or Olanzapine for the Management of Acute Agitation in the Emergency Department: A Within-Trial Analysis
|
Yap, Celene Y. L.
|
|
2017
|
|
2 |
p. 141-151
|
artikel
|
| 53 |
Economic Evaluation of Nivolumab Versus Docetaxel for the Treatment of Advanced Squamous and Non-squamous Non-small Cell Lung Cancer After Prior Chemotherapy in China
|
Hu, Shanlian
|
|
|
|
2 |
p. 273-284
|
artikel
|
| 54 |
Economics of Acromegaly Treatment in Brazil: A Budget Impact Analysis of Pituitary Surgery Compared with Long-Term Octreotide LAR
|
Porto, Lara Benigno
|
|
2018
|
|
2 |
p. 247-254
|
artikel
|
| 55 |
Erratum to: Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations
|
Gabrio, Andrea
|
|
2017
|
|
2 |
p. 143
|
artikel
|
| 56 |
Estimating the Incidence-Based Cost of Illness Due to Hematopoietic Stem Cell Transplantation Using One-Year Insurance Claim Data in Korea
|
Kwon, Sol
|
|
|
|
2 |
p. 189-197
|
artikel
|
| 57 |
Evaluating the Outcomes Associated with Genomic Sequencing: A Roadmap for Future Research
|
Buchanan, James
|
|
2018
|
|
2 |
p. 129-132
|
artikel
|
| 58 |
Evaluation of Advanced Therapy Medicinal Products by the National Institute for Health and Care Excellence (NICE): An Updated Review
|
Pinho-Gomes, Ana-Catarina
|
|
|
|
2 |
p. 147-167
|
artikel
|
| 59 |
Examining Ways to Improve Weight Control Programs’ Population Reach and Representativeness: A Discrete Choice Experiment of Financial Incentives
|
You, Wen
|
|
|
|
2 |
p. 193-210
|
artikel
|
| 60 |
Exploring Patient-Reported Costs Related to Hepatitis C on the Medical Crowdfunding Page GoFundMe®
|
Joseph Mattingly, T.
|
|
|
|
2 |
p. 245-250
|
artikel
|
| 61 |
Framework for Patient Experience Value Elements in Rare Disease: A Case Study Demonstrating the Applicability of Combined Qualitative and Quantitative Methods
|
McQueen, R. Brett
|
|
|
|
2 |
p. 217-228
|
artikel
|
| 62 |
From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy
|
Rossini, Elvio Emanuele
|
|
|
|
2 |
p. 251-261
|
artikel
|
| 63 |
Group Testing for SARS-CoV-2: Forward to the Past?
|
Pouwels, Koen B.
|
|
|
|
2 |
p. 207-210
|
artikel
|
| 64 |
Handling Missing Data in Within-Trial Cost-Effectiveness Analysis: A Review with Future Recommendations
|
Gabrio, Andrea
|
|
2017
|
|
2 |
p. 79-97
|
artikel
|
| 65 |
Healthcare Costs for Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide
|
Rana, Dikshyanta
|
|
|
|
2 |
p. 303-313
|
artikel
|
| 66 |
Health Economic Evaluations of Hemochromatosis Screening and Treatment: A Systematic Review
|
Hoxha, Malvina
|
|
|
|
2 |
p. 147-170
|
artikel
|
| 67 |
Health Economic Evidence of Point-of-Care Testing: A Systematic Review
|
Lingervelder, Deon
|
|
|
|
2 |
p. 157-173
|
artikel
|
| 68 |
Health-Related Quality of Life in Patients Treated with Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis in Singapore
|
Yang, F.
|
|
2017
|
|
2 |
p. 203-208
|
artikel
|
| 69 |
Health State Utilities Associated with False-Positive Cancer Screening Results
|
Matza, Louis S.
|
|
|
|
2 |
p. 263-276
|
artikel
|
| 70 |
Health Technology Assessment of Drugs in Ireland: An Analysis of Timelines
|
Connolly, Emma
|
|
|
|
2 |
p. 287-296
|
artikel
|
| 71 |
High Healthcare Resource Use in Hospitalized Patients with a Diagnosis of Spinal Muscular Atrophy Type 1 (SMA1): Retrospective Analysis of the Kids’ Inpatient Database (KID)
|
Cardenas, Jessica
|
|
2018
|
|
2 |
p. 205-213
|
artikel
|
| 72 |
Impact of a Clinical Pharmacist Intervention on Medicine Costs in Patients with Chronic Obstructive Pulmonary Disease in India
|
Abdulsalim, Suhaj
|
|
|
|
2 |
p. 331-342
|
artikel
|
| 73 |
Impact of a New Cost-Effectiveness Threshold Implementation on Cancer Formulary Decisions in Jordan
|
Treish, Imad
|
|
|
|
2 |
p. 137-145
|
artikel
|
| 74 |
Issues Related to the Frequency of Exploratory Analyses by Evidence Review Groups in the NICE Single Technology Appraisal Process
|
Kaltenthaler, Eva
|
|
2016
|
|
2 |
p. 99-108
|
artikel
|
| 75 |
Learnings for Health Economics from the Early Stages of the COVID-19 Pandemic
|
Hatswell, Anthony J.
|
|
|
|
2 |
p. 203-205
|
artikel
|
| 76 |
Managing Uncertainties Due to Limited Evidence in Economic Evaluations of Novel Anti-Tuberculosis Regimens: A Systematic Review
|
Padmasawitri, T. I. Armina
|
|
|
|
2 |
p. 223-233
|
artikel
|
| 77 |
Measuring the Benefits of Decision Aids for Economic Evaluation
|
Butt, Thomas
|
|
2018
|
|
2 |
p. 143-150
|
artikel
|
| 78 |
Minimally Invasive Sacroiliac Joint Fusion with Triangular Titanium Implants: Cost-Utility Analysis from NHS Perspective
|
Blissett, Deirdre B.
|
|
|
|
2 |
p. 197-209
|
artikel
|
| 79 |
Mixture Cure Models in Oncology: A Tutorial and Practical Guidance
|
Felizzi, Federico
|
|
|
|
2 |
p. 143-155
|
artikel
|
| 80 |
Modelling Survival of Patients Treated with Adjuvant Nivolumab Who Have Melanoma with Lymph Node Involvement or Metastatic Disease After Complete Resection
|
Batteson, Rachael
|
|
|
|
2 |
p. 343-351
|
artikel
|
| 81 |
Model Registration: A Call to Action
|
Sampson, Christopher James
|
|
2017
|
|
2 |
p. 73-77
|
artikel
|
| 82 |
Next-Generation Sequencing in Clinical Practice: Is It a Cost-Saving Alternative to a Single-Gene Testing Approach?
|
Pruneri, Giancarlo
|
|
|
|
2 |
p. 285-298
|
artikel
|
| 83 |
Out-of-Pocket Cancer Care Costs and Value Frameworks: A Case Study in a Community Oncology Practice with a Financial Navigator Program
|
Leopold, Christine
|
|
|
|
2 |
p. 389-392
|
artikel
|
| 84 |
Patient and Physician Preferences for Therapy Characteristics for Psoriasis: A Discrete Choice Experiment in Japan
|
Bolt, Timothy
|
|
2018
|
|
2 |
p. 255-264
|
artikel
|
| 85 |
Raise the Bar, Not the Threshold Value: Meeting Patient Preferences for Palliative and End-of-Life Care
|
McCaffrey, Nikki
|
|
2017
|
|
2 |
p. 93-95
|
artikel
|
| 86 |
Real-World Treatment Patterns, Outcomes, Resource Utilization and Costs in Treatment-Resistant Major Depressive Disorder: PATTERN, a Retrospective Cohort Study in Belgium
|
Gillain, B.
|
|
|
|
2 |
p. 293-302
|
artikel
|
| 87 |
Resources and Costs Associated with the Treatment of Advanced and Metastatic Gastric Cancer in the Mexican Public Sector: A Patient Chart Review
|
Quintana, Miguel
|
|
2017
|
|
2 |
p. 191-201
|
artikel
|
| 88 |
Risk-Sharing Agreements in the EU: A Systematic Review of Major Trends
|
Piatkiewicz, Trevor Jozef
|
|
2017
|
|
2 |
p. 109-123
|
artikel
|
| 89 |
Strimvelis® for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Evaluation
|
South, Emily
|
|
2018
|
|
2 |
p. 151-161
|
artikel
|
| 90 |
Systematic Literature Review of Economic Evaluations, Costs/Resource Use, and Quality of Life in Patients with Mantle Cell Lymphoma
|
Monga, Neerav
|
|
|
|
2 |
p. 175-186
|
artikel
|
| 91 |
The Actual Operative Costs of Liver Transplantation and Normothermic Machine Perfusion in a Canadian Setting
|
Webb, Alexandria N.
|
|
|
|
2 |
p. 311-318
|
artikel
|
| 92 |
The Burden of Caring for Individuals with Tuberous Sclerosis Complex (TSC) Who Experience Epileptic Seizures: A Descriptive UK Survey
|
Skrobanski, Hanna
|
|
|
|
2 |
p. 299-312
|
artikel
|
| 93 |
The Challenge for Orphan Drugs Remains: Three Case Studies Demonstrating the Impact of Changes to NICE Methods and Processes and Alternative Mechanisms to Value Orphan Products
|
Lee, Dawn
|
|
|
|
2 |
p. 175-187
|
artikel
|
| 94 |
The Cost-Effectiveness of a Dance and Yoga Intervention for Girls with Functional Abdominal Pain Disorders
|
Philipson, Anna
|
|
|
|
2 |
p. 321-335
|
artikel
|
| 95 |
The Cost Effectiveness of Mental Health Treatment in the Lifetime of Older Adults with HIV in New York City: A Markov Approach
|
DelaCruz, Juan J.
|
|
|
|
2 |
p. 221-236
|
artikel
|
| 96 |
The Costs of Industry-Sponsored Drug Trials in Canada
|
Tran, Dat T.
|
|
|
|
2 |
p. 353-359
|
artikel
|
| 97 |
The Economic Burden of Small Cell Lung Cancer: A Systematic Review of the Literature
|
Enstone, Ashley
|
|
2017
|
|
2 |
p. 125-139
|
artikel
|
| 98 |
The Efficiency of Increased HCV Testing and Treatment Strategies in Spain to Achieve Elimination Goals
|
Calleja, Jose Luis
|
|
|
|
2 |
p. 221-233
|
artikel
|
| 99 |
The Impact of Brexit on Pharmaceuticals and HTA
|
Lorgelly, Paula K
|
|
2018
|
|
2 |
p. 87-91
|
artikel
|
| 100 |
The Impact of Digital Health Interventions for the Management of Type 2 Diabetes on Health and Social Care Utilisation and Costs: A Systematic Review
|
Morris, Tiyi
|
|
|
|
2 |
p. 163-173
|
artikel
|
| 101 |
The Psychometric Properties of a Self-Administered, Open-Source Module for Valuing Metastatic Epidural Spinal Cord Compression Utilities
|
Pahuta, Markian
|
|
2018
|
|
2 |
p. 197-204
|
artikel
|
| 102 |
The Societal Economic Impact of Secukinumab in First-Line Treatment of Moderate to Severe Plaque Psoriasis in Germany: An Open-Cohort Simulation
|
Seddik, Ahmed H.
|
|
|
|
2 |
p. 265-275
|
artikel
|
| 103 |
Ticagrelor Removal by CytoSorb® in Patients Requiring Emergent or Urgent Cardiac Surgery: A UK-Based Cost-Utility Analysis
|
Javanbakht, Mehdi
|
|
|
|
2 |
p. 307-319
|
artikel
|
| 104 |
Time and Cost of Hospitalisation for Salvage Therapy in Adults with Philadelphia Chromosome-Negative B Cell Precursor Relapsed or Refractory Acute Lymphoblastic Leukaemia in Spain
|
Boluda, Blanca
|
|
2018
|
|
2 |
p. 229-235
|
artikel
|
| 105 |
Time Trade-Off Utilities for Hereditary Angioedema Health and Caregiver States
|
Lo, Siu Hing
|
|
|
|
2 |
p. 231-239
|
artikel
|
| 106 |
Touch for Health: Use of Pavlovian Processes with Physical Touch as a Means to Improve Menstrual Hygiene Management Initiatives, Measured by Willingness to Pay
|
Yilmaz, Siobhan K.
|
|
|
|
2 |
p. 263-276
|
artikel
|
| 107 |
Treatment Costs of Basal Insulin Regimens for Type 2 Diabetes Mellitus in France
|
Detournay, Bruno
|
|
|
|
2 |
p. 211-219
|
artikel
|
| 108 |
Treatment Patterns and Costs Associated with Stage IV Non-Small Cell Lung Cancer in a Mexican Population: A Chart Review
|
Alatorre, Jorge Arturo
|
|
|
|
2 |
p. 381-388
|
artikel
|
| 109 |
Treatment-Related Healthcare Costs of Metastatic Castration-Resistant Prostate Cancer in Germany: A Claims Data Study
|
Kreis, Kristine
|
|
|
|
2 |
p. 299-310
|
artikel
|
| 110 |
Understanding Patients’ Willingness to Pay for Biphasic Insulin Aspart 30/70 in a Pen Device for Type 2 Diabetes Treatment in an Out-of-Pocket Payment Market
|
Murthy, Sreenivasa
|
|
|
|
2 |
p. 261-273
|
artikel
|
| 111 |
Understanding the Natural History of Chronic Hepatitis D: Proposal of a Model for Cost-Effectiveness Studies
|
Kaushik, Ankita
|
|
|
|
2 |
p. 333-343
|
artikel
|
| 112 |
Uterotonic Drugs for the Prevention of Postpartum Haemorrhage: A Cost-Effectiveness Analysis
|
Pickering, Karen
|
|
2018
|
|
2 |
p. 163-176
|
artikel
|
| 113 |
Utilization, Spending, and Price Trends for Quinolones in the US Medicaid Programs: 25 Years’ Experience 1991–2015
|
Almalki, Ziyad S.
|
|
2016
|
|
2 |
p. 123-131
|
artikel
|
| 114 |
Value of Information Analysis: Are We There Yet?
|
Tuffaha, Haitham
|
|
|
|
2 |
p. 139-141
|
artikel
|
| 115 |
Working with Patients and Members of the Public: Informing Health Economics in Child Health Research
|
Kandiyali, Rebecca
|
|
2018
|
|
2 |
p. 133-141
|
artikel
|
Tijdschrift beschrijving